Impact of Translational Research on Optimization of Neonatal Cardiopulmonary Bypass Circuits and Techniques—The Penn State Health Approach
Akif Undar,Shigang Wang,David A. Palanzo,Robert Wise,Karl Woitas,Larry D. Baer,Allen R. Kunselman,Joseph B. Clark,John L. Myers
DOI: https://doi.org/10.1111/aor.12906
2017-01-01
Artificial Organs
Abstract:Translational research is a “bench-to-bedside and beyond” approach which transforms scientific discoveries during engineering and basic science research in the laboratory and preclinical studies into clinical applications to improve the quality of healthcare. The goal of translational research is to provide scientific evidence for decision-making on actions to improve health. The experimental design, conduct, analysis, and conclusion of the study must strictly follow the scientific method. More importantly, experiments must have the ability to be duplicated. Additionally, translational research must be conducted at independent institutions without financial incentive or other personal benefit from the projects. Therefore, regarding the selection of components of cardiopulmonary bypass (CPB) circuitry, translational research is mandatory, not optional, both for the safety of neonatal and pediatric cardiac patients undergoing CPB procedures as well as for saving the institutional resources. Over the past 13 years at Penn State Health Children's Hospital and College of Medicine, our multi-disciplinary research team has established the Pediatric Cardiovascular Research Center with the goal of improving the outcomes for children undergoing cardiac surgery with CPB procedures. Currently, every CPB component used in our clinical setting at Penn State Health has been selected based on the results of our translational research projects. This editorial will summarize these translational research projects for neonatal CPB patients in the Penn State Health Pediatric Cardiovascular Research Center and will share the latest results with all interested readers. Blood pumps are dynamic sources for the CPB circuit to transfer blood back into the patient's systemic circulation and to provide hemodynamic energy for systemic perfusion. There are two main types: the roller pump and the centrifugal pump. During conventional neonatal and pediatric CPB procedures, roller pumps are still widely used mainly due to their ease of use and low cost. While the use of centrifugal pumps has increased for adult cardiac surgery, they remain in limited use for the pediatric and neonatal population. The most recent survey results of international pediatric perfusion practice demonstrated that 64% of all responding centers reported the exclusive use of roller pumps for the arterial pump, only 5% reported the exclusive use of centrifugal pumps, and 30% reported some use of each type of pump 1. Besides the increased cost of the centrifugal pump head, some of the reasons for choosing a roller pump over a centrifugal pump for neonatal and pediatric CPB is the issue of retrograde flow and the need for tighter control and accuracy of flow. For lower flow rates, the accuracy of the centrifugal pump is questioned. This requires an additional inline flow meter to verify the actual flow that is being delivered to the patient. With the need for fine tuning the flow especially during low flow states and/or antegrade cerebral perfusion, when your maximum flow may only be in the range of 120–150 mL/min, it is vitally important to have a pump that can meet those needs. Currently, the roller pump is the pump of choice for those situations. The occlusive nature of the roller pump can prevent backflow and more easily generate pulsatile flow. Almost all contemporary roller pumps are equipped with a pulsatile mode. Pulsatile flow during CPB procedures is considered to be superior to nonpulsatile flow at preserving microcirculation 2, 3. We have tested six pediatric CPB pumps in piglet models and found that the majority generated significantly higher hemodynamic energy than the conventional, nonpulsatile pumps 4. The pulsatile setting has a significant impact on the hemodynamic output 5. As new blood pumps launch, it is essential to thoroughly evaluate them to select the best one for use in clinical practice. The oxygenator is one of the primary components of the CPB circuit for blood gas exchange and temperature control with an integrated heat exchanger. The oxygenator structure, physical characteristics of the hollow fiber, and surface coating greatly impact gas exchange, blood trauma, and activation. Different manufacturers produce very distinct oxygenators. Therefore, it is necessary to independently evaluate the oxygenators on the market to select the best one before it is used for patients. We performed in vitro evaluations of several pediatric oxygenators, including those with and without an integrated arterial filter, in terms of the transmembrane pressure gradient, hemodynamic energy transmission, and gaseous microemboli (GME) handling ability 6-10. Oxygenators with lower priming volume, lower transmembrane pressure gradient, higher gas exchange efficiency, and higher GME capturing ability are recommended. Although an open arterial filter purge line can remove more GME than a closed purge line, it is noted that the returned blood from the purge line may compromise the GME handling ability of the venous/cardiotomy reservoir 11. The new generation hollow fiber membrane oxygenators with integrated arterial filters have replaced the separate arterial filters to reduce priming volume without losing filtration ability. Our in vitro studies showed that the integrated arterial filter minimally influences the hemodynamics of the circuit but that the GME capturing ability may be slightly affected, likely due to the different integrated GME filtering methods 9. The arterial and venous cannulae are two bridges that connect the CPB circuit to the patient's body. The arterial cannula is the narrowest part of the CPB circuit. High flow rates, high pressures, high shearing forces, turbulence, and cavitation may lead to physical and physiological changes of the blood cells passing through it. High flux arterial cannulae with low-pressure gradients are expected to minimize these adverse effects on blood cells. This is even more important for neonatal arterial cannulae because neonatal patients have relatively small vessels and require higher flow rates per body surface area to meet metabolic demands in comparison to adults. We have evaluated several neonatal arterial cannulae available in the United States and found that the same labeled size arterial cannulae across different brands perform variably 12, 13. To select an appropriate arterial cannula for the CPB circuit, the expected maximum flow rate necessary to prevent high circuit resistance should be considered. Additionally, using a computational fluid dynamics (CFD) simulation, we found that the arterial cannula tip geometry can significantly affect the circuit's fluid dynamics; a diffuser cannula tip has passive jet flow control, hemodynamic performance and reduced exit force 14. It is urgently necessary for clinicians and scientists to develop high-flow/low-resistance arterial cannulae for neonatal extracorporeal life support and CPB procedures. The arterial and venous tubing are used to connect the oxygenator to the circulatory system in patients through the arterial and venous cannulae. Because the conventional CPB venous drainage relies on gravity siphon drainage, the venous tubing cannot be shortened sufficiently to reduce the total priming volume of the circuit. Larger venous tubing will provide adequate venous drainage, but resultant hemodilution is unavoidable, especially in neonates. Alternatively, vacuum-assisted venous drainage (VAVD) can augment venous drainage by adding appropriate negative pressure to a closed venous system. Although the VAVD technique has been widely used in pediatric CPB procedures, it is worth noting that VAVD carries the potential risks of increased negative pressure in the right atrium, over-pressurization of the sealed venous/cardiotomy reservoir, increased shunting from the arterial filter purge line, and transmission of GME from the venous line to the arterial line. Our in vitro study demonstrated that VAVD with high vacuum levels can deliver entrained venous air into the arterial line, especially at increased pump flow rates and with the use of pulsatile flow 15. Careful regulation of the vacuum levels will optimize the venous drainage and minimize its side effects. The resistance of the arterial tubing directly impacts the CPB circuit pressure and hemodynamic energy transmission created by the blood pump. There is no doubt that a larger inner diameter and shorter tubing length will reduce the resistance in the arterial line. We have evaluated 1/8 in., 3/16 in., and 1/4 in. arterial and venous tubing, and found that, although arterial tubing with a smaller diameter (<1/4 in.) slightly decreased CPB priming volume, it could lead to significantly higher circuit pressures, higher pressure drops, and more hemodynamic energy loss across the CPB circuit 12, 13. In terms of hydrodynamic performance, large diameter arterial tubing is recommended during pediatric CPB procedures. In clinical practice, various ultrafiltration techniques can compensate for the disadvantage of the increased priming volume associated with larger diameter arterial and venous tubing. The use of modified ultrafiltration (MUF) immediately post-CPB has been shown to reduce inflammatory mediators, improve cardiac function and reduce pulmonary vascular resistance after CPB 16. At our institution, the goal immediately post-CPB is to concentrate the entire circuit volume and patient's blood volume until the patient's hemoglobin is equal to or greater than 15 g/dL as measured off of the MUF circuit. This usually results in the patient's hemoglobin being greater than 13.5 g/dL in the immediate postoperative period. The arterial filter is the final checkpoint in the CPB circuit through which blood passes before entering the patient. The purpose of this filter is to prevent solid particles and gaseous emboli from entering the patient's body during the CPB procedure. Therefore, it is necessary to conduct translational research to select the arterial filter that will most effectively minimize the risk of embolic neurologic events. We have tested several pediatric arterial filters and found that they are equally effective at removing GME in a simulated CPB circuit 17, 18. An open arterial filter purge line can enhance GME removal ability. According to our results, an arterial filter is not an option but rather a necessity for removing microemboli before they reach the patient. New techniques in oxygenator manufacturing make it possible to integrate an arterial filter into an oxygenator to simplify the CPB circuit and reduce the priming volume. A secondary reservoir for pump suckers will further minimize microemboli generation in CPB circuits 19. Shunt flow generated by the open purge line of the arterial filter is frequently neglected by perfusionists. Filter manufacturers insist on leaving an open purge line on the arterial filter to remove more GME from the arterial blood delivered to the patients. However, the shunt flow from the arterial filter purge line is not typically monitored by the perfusionists during CPB, and often the displayed flow rate on the heart-lung machine is considered to be the “real” flow rate delivered to the patient. In adult patients, high pump flow rates will mask this small proportion of “stolen” blood flow from an open purge line. In neonates and infants, however, the relatively large proportion of shunted flow may lead to inadequate end-organ perfusion and tissue hypoxia during CPB procedures, especially after rewarming. Our in vitro studies demonstrated that a significant amount of flow is diverted away from the patient when the arterial purge line is open 20. For example, at pump flow rates of 200–600 mL/min, the purge line diverted 87.7 mL/min (42.6%)−76.3 mL/min (12.8%) of pump flow at the post-filter pressure 60 mm Hg, and 169.7 mL/min (82.2%)−154.5 mL/min (25.9%) of pump flow at the post-filter pressure 180 mm Hg. Low pump flow rates and high post-filter pressures will lead to more purge line shunt flow and ultimately to less effective tissue perfusion in the patient. A flow probe (distal to the arterial filter) is strongly recommended for use in the circuit to monitor real-time arterial flow in the setting of an open arterial filter purge line. Real-time monitoring of GME during CPB procedures can help the surgical team find the source of air entering into the circuit. Air is easily sucked into the CPB circuit at the low-pressure side of the CPB tubing (venous line) and at the cardiotomy/venous reservoir. Adding other devices to the circuit, such as a hemoconcentrator and hemofilter, introduces additional risks of GME entry into the circuit. The surgeon and perfusionist's manipulations of the circuit during the procedure also increase the risk for air entry. A large spike in GME count or volume during real-time monitoring of the CPB circuit would serve to warn the surgical team of a new source of air entry into the circuit so this issue can be promptly addressed. In our operating room, two Emboli Detection and Classification (EDAC) probes are inserted into the venous and arterial lines to monitor GME entry into the circuit and delivery to the patient. Our clinical studies demonstrated that the venous line is the main source of GME, particularly when using VAVD 21, 22. The negative pressure in the venous reservoir added by VAVD may increase the formation and delivery of GME. The residual air in the venous line would then transfer more GME to the patient. Adding volume through the arterial line before and after CPB also has the potential to introduce more GME. Pulsatile flow and hypothermia further increase the probability that GME will be delivered to the patient. Therefore, careful management of CPB is required to minimize GME-related postoperative complications. The cardioplegia delivery system is designed to deliver crystalloid or blood cardioplegia into the ascending aorta or coronary sinus to temporarily stop cardiac activity and prevent myocardial injury during aortic cross-clamping. In particular cases, it can be used for isolated limb infusion, rapid infusion, and MUF. Therefore, a bubble trap within the cardioplegia delivery system is very important for prevention of GME-related organ or tissue impairment after cardiac surgery. We have evaluated six cardioplegia delivery systems available in the United States in terms of the volume, count, and size distribution of the GME under hypothermic and normothermic temperatures using the EDAC Quantifier. We found that the air-handling ability of the cardioplegia delivery system was dependent on the temperature and flow rate of the solution running through the device 23. Clinical perfusionists should select the best cardioplegia delivery system according to the practical clinical application. Brain protection in pediatric patients undergoing CPB procedures is still a major concern to clinicians, especially during selective cerebral perfusion and deep hypothermic circulatory arrest. The immature brain, with its imperfect cerebrovascular autoregulation and ongoing brain development, is susceptible to neurological impairments after cardiac surgery 24, 25. Intraoperative neuromonitoring is used at our institution to help minimize neurologic injury and improve outcomes. We use a multimodality approach to intraoperative neuromonitoring 26. We routinely use near-infrared spectroscopy (NIRS), electroencephalography, transcranial Doppler (TCD) ultrasound, and somatosensory evoked potentials for all patients undergoing CPB for pediatric congenital heart surgery. Interpretation of the multimodal data is performed by the neurophysiologist present in the operating room. Any adverse or concerning parameters are communicated to the team and attempts are made for corrective intervention. We are interested in incorporating pulsatile perfusion during pediatric CPB procedures, as pulsatile flow is considered to be superior to non-pulsatile flow in microcirculatory perfusion and may play a role in helping to preserve brain function. We analyzed clinical data consisting of regional cerebral oxygen saturation (rSO2) levels and a cerebrovascular pulsatility index (PI) measured by NIRS and TCD in pediatric patients undergoing CPB procedures. We showed that pulsatile flow has advantages over nonpulsatile flow in terms of rSO2 and PI, especially at advanced time points, which may improve postoperative neurodevelopmental outcomes 27. We also used CFD to elicit the significant role that the arterial cannula tip design and orientation have in head–neck perfusion during CPB 28. These results showed that aortic cannulation with an end-hole tip is likely to lead to backflow from the brachiocephalic artery by the high speed cannula jet stream. Altering the end-hole tip design to a diffuser cone led to significant improvements for head–neck perfusion. Translational research, using a multi-disciplinary approach, is a practical tool to bridge scientific discoveries with clinical application for improving human health. In vitro and in vivo parallel comparison and evaluation of CPB devices allow for rapid selection of the most effective components of the CPB circuit for neonatal patients, while providing valuable advice to manufacturers for product improvement. Akif Ündar, PhD, Shigang Wang, MD, David A. Palanzo, CCP, Robert Wise, CCP, Karl Woitas, CCP, Larry D. Baer, CCP, Allen R. Kunselman, MA, Joseph B. Clark, MD, and John L. Myers, MD Department of Pediatrics, Pediatric Cardiovascular Research Center Penn State College of Medicine Penn State Health Children's Hospital Hershey, PA, USA E-mail: aundar@psu.edu E-mail: swang2@hmc.psu.edu E-mail: dpalanzo@hmc.psu.edu E-mail: rwise@hmc.psu.edu E-mail: kwoitas1@hmc.psu.edu E-mail: lbaer@hmc.psu.edu E-mail: ark3@psu.edu E-mail: jclark7@hmc.psu.edu E-mail: jmyers3@hmc.psu.edu Akif Ündar, PhD, Joseph B. Clark, MD, and John L. Myers, MD Department of Surgery Penn State College of Medicine Penn State Health Children's Hospital Hershey, PA, USA Akif Ündar, PhD Department of Bioengineering Penn State College of Medicine Penn State Health Children's Hospital Hershey, PA, USA David A. Palanzo, CCP, Robert Wise, CCP, Karl Woitas, CCP, and Larry D. Baer, CCP Department of Perfusion Penn State College of Medicine Penn State Health Children's Hospital Hershey, PA, USA Allen R. Kunselman, MA Department of Public Health and Sciences Penn State Health Milton S. Hershey Medical Center Penn State College of Medicine Penn State Health Children's Hospital Hershey, PA, USA